Advances in Contemporary Research Advanced Synthetic And

Total Page:16

File Type:pdf, Size:1020Kb

Advances in Contemporary Research Advanced Synthetic And Indian Journal of Chemistry Vol. 55B, July 2016, pp. 833-853 Advances in Contemporary Research Advanced synthetic and pharmacological aspects of 1,3-oxazoles and benzoxazoles Ambreen Ghani*, Erum A Hussain, Zubi Sadiq & Narjis Naz Department of Chemistry, Lahore College for Women University, Lahore 54000, Pakistan E-mail: [email protected]; [email protected] Received 9 December 2014; accepted (revised) 31 March 2016 Broad bio-spectrum of 1,3-oxazole and benzoxazole has created an attractive platform for synthetic chemists to introduce structural modification in its nucleus by straight forward access to new approaches. Owing to its fascinating features and interesting pharmacological activities, many researchers have proved that oxazole is an active agent in treating different diseases. Based on this fact, this article outlines intramolecular and two component intermolecular cyclization to oxazoles and benzoxazoles. The theme is well documented in this review article covering the era from 2007 till present. Moreover, bioactivity and mechanistic insights are provided with different synthetic approaches, encompassing various pathways. Keywords: Benzoxazole, bisoxazole, oxazole, synthesis, bioactivity Oxazole, a heterocyclic scaffold is believed to occur overcome the limitations of multi-step processes11-14. in various structurally complex biologically active The amazing pharmacological profile of oxazole natural products. Several oxazole possessing includes antibiotic, anti-inflammatory, hyperglycemic, compounds have been isolated from plants and marine antiproliferative, antihistaminic, antiparasitics and natural origins such as Martefragin A and Almazol D anti-tuberculosis activities15-17. For instance, the use of (Figure 1) isolated from Martensia fragiles1 and red drug containing oxazole is oxaprozin having non- algae2 respectively. These naturally occurring steroidal anti-inflammatory activity. Owing to its molecules demonstrate the versatile synthetic, privileged importance, a lot of work has been done on medicinal and industrial applications of oxazoles. The synthesis and medicinal features of oxazoles18. diversified oxazole analogues with multi-directional To the best of our knowledge, previous reviews19 potential stands out in modern organic chemistry and on oxazole focused on specific aspects of its synthesis provides the sharp sword that combat future were published during 2008 to 2014. We hereby wish challenges related to medicinal and synthetic aspects. to describe synthetic routes involving metal catalyzed, Considerable attention has been made in metal free, microwave assisted and different formulating high yield synthetic approaches from multicomponent domino approaches adopted for simpler chemical catalog. Generally, this widespread oxazoles. Metal catalyzed procedures have been highly substituted building block is attained from studied by emphasizing their specificity, while their intramolecular cyclocondensation reactions using promising mechanistic insight has also been provided. dehydrating agents or by intermolecular cyclization Metal free transformations for oxazoles, contribute a through α-substituted ketones as intermediates3-10. great deal in organic synthesis. Microwave Nevertheless, direct eco-friendly metal catalyzed technology being highly preferred method of heating approaches have also been extensively used that provides better possibilities in chemical synthesis. While MCR approach offer a clear direction with NH atom economy, ecofriendly simplified steps and RO N effective use of resources for 1,3-oxazoles. OOC O N O In the preceding sections a brief description of O N numerous synthetic strategies and pharmacological implications of 1,3-oxazole hetrocycles is presented in N N H H order to provide an idea for future directions on this Figure 1 — Oxazoles from natural sources potential molecule. 834 INDIAN J. CHEM., SEC B, JULY 2016 Intramolecular Cyclization X ° O O [Cu], H2O, 120 R' Amide based oxazoles ' N R N R R Benzo[d]oxazole 2 was successfully synthesized from H R2N NR2 1 2 intramolecular O-arylation of haloanilides 1 using feasible 20 protocols . This direct approach was environmentally Scheme I benign and highly cost effective due to open choice in copper salt and simple diamine derivatives, Scheme I. A direct approach to 2-substituted 5-oxazole The copper catalyzed oxidative cyclization of carbaldehydes was achieved by palladium (II) salt enamides furnished 2,5-disubstituted oxazoles in two catalyzed intramolecular heterocyclization of alkyl, 21 steps from alkyne and simple amide precursors . An aryl and heteroaryl propargylamides27. interesting synthesis of 2-phenyl-4,5-substituted N-Propargylamides also produced 2,5-disubstituted oxazoles in a couple of steps involving copper mediated oxazoles with aryl iodides by same catalyst through intramolecular cyclization of substituted β-(methylthio) in situ cyclization of coupling product28. enamides was reported. Two steps copper promoted Various rhodium catalysts for cyclodehydration cyclization of β-(methylthio)enamides generated and carbene N-H insertion were used successfully to from 4-[(methylthio)hetro(aryl)methylene]-2-phenyl- achieve regioselective sulfones, phosphonates and 5-oxazolones afforded functionalized 2-phenyl-4,5- carboxylates of oxazoles and thiazoles29. The substituted oxazoles. Texamine and uguenenazole, α-silylalkyl benzoxazoles 6a and oxazoles 6b were two natural, 2, 5-diaryloxazoles were furnished prepared from silyldiazoketones 3 via silylketenes 4 through hydrolysis and decarboxylation of 2,5- which subsequently combined with amino malonate diaryloxazole-4-carboxylates. Furthermore, oxazole- and amino phenols followed by cyclocondensation to 4-carboxamides derived from serine to trisubstituted give desired products (Scheme II)30. 4,2-bisoxazoles was elaborated via diethylaminosulfur Greatly regioselective migration of the sulfonyl trifluoride/1,8-diazabicyclo[5.4.0] undec-7-ene group lead to functionalized oxazoles 8a and 8b by (DAST/DBU) facilitated through cyclodehydration- virtue of silver (I) promoted [3,3] rearrangement of 22 dehydrohalogenation arrangement . N-sulfonyl propargylamide 7 (Scheme III)31. Nucleophilic ring opening of 4-[(methylthio) Silver promoted cyclization of amides and hetro(aryl)methylene]-2-phenyl-5-oxazolone was obtained α-bromoketones in microwave was determined by by alkyl/aryl grignard reagents, amino acid esters, Bailey. The scope of the reaction was extended to amines and alkoxides, so different functionalities like both the variety of silver catalyst and amide substrates ester, acyl, N-substituted carboxamide were to produce highly functionalized 2,4 and 2,4,5 introduced at C-4 of oxazole. Regioselective substituted oxazoles32. functionalized molecules of 2-arylbenzoxazoles were Atom-economic approach was adopted to have a prepared by copper-mediated intramolecular oxidative group of functionalized 2,5-disubstituted oxazoles 10 23 coupling of benzanilides . from propargylic amides 9 catalyzed by gold to Fabrication of alkyl, aryl, hetero aryl and vinyl alkylidene oxazolines, followed by autoxidation to substituted oxazoles by copper catalyzed oxidative hydroperoxides (Scheme IV)33. cyclization of enamides through functionalization of Various important oxazoles from enamides by 24 vinylic C-H bond was obtained by Cheung . phenyliodinediacetate mediated intramolecular More recently, Panda revealed a proficient one pot cyclization were achieved. The extensive substrate annulation of enamides to 2,5 and 2,4,5-substituted choice and metal free oxidative carbon-oxygen bond 34 oxazoles through NBS/Me2S catalysed reaction in formation was the main characteristics of this method . mild base. The scope of this method has been A transition metal free protocol to present thoroughly explored including both electron donating quinoline, pyridine and coumarin annulated oxazoles 25 and withdrawing groups . An efficient, simple and (Figure 2) using Cs2CO3 through intramolecular ligand-free preparation of substituted benzoxazoles, nucleophilic cyclization of o-bromoamides to benzimidazoles, 2-aminobenzothiazoles and 2-amino fabricate C-O bond for oxazoles was exposed35. benzimidazoles were carried out from o-bromoaryl A catalyst free domino strategy was adopted to derivatives via intramoleculer cyclization through assemble 2-acyloxazoles from arylacetylenes, methyl 26 recoverable copper (II) oxide nanoparticles . ketones, or arylethenes via successive iodination/ GHANI et al.: 1,3-OXAZOLES AND BENZOXAZOLES 835 O O Rh (oct) O O SiR 2 4 C -NH2-C6H6OH R R 3 N R SiR H N2 3 SiR3 OH 4 3 5a CO2Et NEt NEt3 PPh3, DEAD 3 EtO2C NH3Cl O CO Et R O OEt 2 R O R PPh3, I2 N CO Et N 2 R Si N R3Si CO2Et H 3 NEt3 SiR3 6a 6b 5b Scheme II O COOH O Au1 AgBF R O O 4 2 O RN R2 O R 2 H O2 R N R1 N O 9 10 O Ts 8a Scheme IV R1 N R2 CO2CH3 CO2CH3 Ts O DBU, ACN 7 Et3N N R2 HN AgBF R N Br/I O 4 1 R O R 8b 11 12 Scheme III Scheme V O O Cl O Me EtN O O O N N N N Br Figure 2 — Cesium catalyzed oxazoles Kornblum oxidation/cyclization36. 2,5-Disubstituted Robinson-Gabriel synthesis utilizing β-oxotryptophan oxazole-4-carboxylate 12 was synthesized from and β-oxotryptamine methyl ester with chiral methyl esters of N-acyl-β-halodehydroamino butyric ketoamides leading to target molecule. This revision acid 11 in 2% DBU-acetonitrile, for investigating was justified on the basis of NMR and optical activity photophysical properties (Scheme V). All the of synthetic and natural Almazole D2. derivatives showed moderate solvent
Recommended publications
  • An Integrated Flow and Batch-Based Approach for the Synthesis of O-Methyl Siphonazole Amarcus Combined Flow and Batch Synthesis of O-Methyl Siphonazole Baumann, Ian R
    LETTER 1375 An Integrated Flow and Batch-Based Approach for the Synthesis of O-Methyl Siphonazole AMarcus Combined Flow and Batch Synthesis of O-Methyl Siphonazole Baumann, Ian R. Baxendale, Malte Brasholz, John J. Hayward, Steven V. Ley, Nikzad Nikbin Innovative Technology Centre, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK E-mail: [email protected] Received 21 February 2011 has transformed flow chemistry from an academic interest Abstract: The bisoxazole containing natural product O-methyl si- phonazole was assembled using a suite of microreactors via a flow- to a valuable enabling technology that overcomes several based approach in concert with traditional batch methods. The use of the bottlenecks traditionally faced by synthetic chem- 6 of a toolbox of solid-supported scavengers and reagents to aid puri- ists. As such the generation and immediate use of hazard- fication afforded the natural product in a total of nine steps. ous, toxic, or unstable intermediates7 has been reported as Key words: oxazoles, Claisen condensation, flow chemistry, well as the possibility to more reliably perform reaction microreactors, solid-supported reagents scale-up.8 Furthermore, flow reactors can be transformed into automated platforms by the addition of liquid han- dling and fraction collector modules expanding the work- As part of our ongoing interest in oxazole-containing nat- ing capabilities of the units and allowing for 24/7 working 9 ural products,1 we have devised a synthetic route to the regimes. Finally, individual reactions can be telescoped bisoxazole alkaloid O-methyl siphonazole (2), which was into one continuous flow sequence, thus avoiding the iter- discovered by König and co-workers in 2006, along with ative isolation, purification, and reprocessing of interme- 10 the C-21-demethylated parent compound siphonazole (1, diates.
    [Show full text]
  • UV-Curable Coating Composition
    Europaisches Patentamt European Patent Office (fi) Publication number: 0 001 466 A1 Office europeen des brevets EUROPEAN PATENT APPLICATION 2y Application number: 78200215.8 © int. ci.*: C 09 D 3/49, C 08 F 299/00, C 08 F 2/50 §) Date of filing: 28.09.78 © Priority: 11.10.77 NL 7711121 Applicant: Akzo N.V., Ijssellaan 82, NL-6800 LS Arnhem (NL) (7g) Inventor: Noomen, Arie, Schoonoord 22, NL-2215 Ed @ Date of publication of application: 18.04.79 Voorhout (NL) Bulletin 79/8 Inventor: Wolters, Egbert, Potgieterstraat 21, NL-1053 XP Amsterdam (NL) @ Representative: Sieders, Rene et ai, P.O.Box 314, @ Designated Contracting States: BE DE FR GB NL SE NL-6800 AH Arnhem (NL) @ U.V.-curable coating composition. The invention relates to a coating composition which is curable under the influence of ultraviolet light and which comprises a U.V.-curable binder, a photoinitiator and as accelerator a tetrahydro-1,3-oxazine compound and/or an oxazolidine compound. The U.V.-curable binder is pref- erably an adduct containing at least one isocyanate group of a) an acrylic or methacrylic hydroxy ester having 5 to 20 carbon atoms and b) a polyisocyanate having 4 to 40 carbon atoms and 2 to 4 isocyanate groups. The invention relates to a coating composition which can be cured under the influence of ultraviolet light ;and is based on a U.V.-curable binder, a photoinitiator and a nitrogen-containing accelerator. In known com- positions useismade generally of an aromatic carbonyl compound as photoinitiator, and of an alkanolamine as accelerator.
    [Show full text]
  • Phamarcological Effects Produced by the Modifications in Isoxazole Moeities
    Archana c. et al. / Asian Journal of Phytomedicine and Clinical Research. 4(1), 2016, 29 - 32. Review Article CODEN: AJPCFF ISSN: 2321 – 0915 Asian Journal of Phytomedicine and Clinical Research Journal home page: www.ajpcrjournal.com PHAMARCOLOGICAL EFFECTS PRODUCED BY THE MODIFICATIONS IN ISOXAZOLE MOEITIES C. Archana *1 , E. Akila 2, Priya john 3 1*Department of Pharmaceutical Chemistry, Prime College of Pharmacy, Palakkad, Kerala, India. 2Department of Pharmacognosy, Prime College of Pharmacy, Palakkad, Kerala, India. 3Department of Pharmacology, Prime College of Pharmacy, Palakkad, Kerala, India. ABSTRACT Isoxazole and its derivatives are an important class of heterocyclic compound displaying a broad spectrum of biological activities which have made them privileged structures. In the present work, attempts were made to identify leading isoxazole moieties as candidate drugs against many diseases. For example, isoxazole substituted 9-anilino acridine derivatives was found to have increased antioxidant activities. The molecular docking studies show a good correlation between their biological activities screened and auto dock binding free energy. These derivatives will encourage helping to design future anti cancer agents with higher therapeutic potential. Another example is isoxazole incorporated 2-quinolones to show increased antimicrobial and anti inflammatory activities. More importantly, various isoxazole derivatives greatly increase biological properties of the structure like anti-infective action, anticancer properties, anti-protozoal and mutagenic properties. A modification in their structures has offered a high degree of diversity that has proven useful for the development of new therapeutic agents having improved potency and lesser toxicity. In the present study of concise review, is provided on the activities of isoxazole and its derivatives which involve history, chemistry, different methods of synthesis of isoxazole with biological activities and docking studies.
    [Show full text]
  • Recent Syntheses of Steroidal Oxazoles, Oxazolines and Oxazolidines
    A Platinum Open Access Journal Review for Organic Chemistry Free to Authors and Readers DOAJ Seal Arkivoc 2021, part i, 471-490 Recent syntheses of steroidal oxazoles, oxazolines and oxazolidines Besma Bendif,a,b Malika Ibrahim-Ouali,*a and Frédéric Dumur c aAix Marseille Univ, CNRS, Centrale Marseille, iSm2, F-13397 Marseille, France bLaboratoire de Chimie Appliquée, Faculté des Sciences, Université du 08 mai 1945 Guelma, Algeria cAix Marseille Univ, CNRS, ICR, UMR 72 73, F-13397 Marseille, France Email: [email protected] Received 03-15-2021 Accepted 04-11-2021 Published on line 05-08-2021 Abstract It was found that the introduction of heterocycles to steroids often leads in a change of their physiological activity and the appearance of new interesting biological precursors. Recent developments in the syntheses of steroidal oxazoles, oxazolines, and oxazolidines are described herein. The biological activities of those steroidal derivatives for which data are available are given. Keywords: Steroids, oxazoles, oxazolines, oxazolidines DOI: https://doi.org/10.24820/ark.5550190.p011.512 Page 471 ©AUTHOR(S) Arkivoc 2021, i, 471-490 Bendif, B. et al. Table of Contents 1. Introduction 2. Synthesis of Steroidal Oxazoles 3. Synthesis of Steroidal Oxazolines 4. Synthesis of Steroidal Oxazolidines 5. Conclusions Acknowledgements References 1. Introduction Steroids constitute an extensive and important class of biologically active polycyclic compounds that are widely used for therapeutic purposes.1-3 Even after decades of research, the total synthesis of steroid nuclei by improved strategies continues to receive considerable attention. Numerous methods have been exploited for the total synthesis of steroids which are widely distributed in nature and which possess practical medical importance.
    [Show full text]
  • Isoxazoles: Molecules with Potential Medicinal Properties
    IJPCBS 2013, 3(2), 294-304 Jayaroopa et al. ISSN: 2249-9504 INTERNATIONAL JOURNAL OF PHARMACEUTICAL, CHEMICAL AND BIOLOGICAL SCIENCES Available online at www.ijpcbs.com Research Article ISOXAZOLES: MOLECULES WITH POTENTIAL MEDICINAL PROPERTIES K. Ajay Kumar and P. Jayaroopa* Post Graduate Department of Chemistry, Yuvaraja’s College, University of Mysore, Mysore-570 005, India. ABSTRACT Isoxazole is a five membered heterocyclic compound having various pharmacological actions. The great interest associated with isoxazoles and their derivatives is based on their versatility as synthetic building blocks, their latent functionalities as enaminones, 1,3-dicarbonyl compounds, γ-amino alcohols, and β-hydroxy nitriles have been widely exploited for the synthesis of other heterocycles and complex molecules. This review paper comprises of up to date information on isoxazole analogs. More emphasis was given to critical discussion on the synthetic strategy of isoxazole derivative, their utility as building blocks in their transformation to more biologically potent molecules. Results of isoxazole derivatives and their substitutions effect on diverse biological activities also presented. Keywords: Isoxazoles, antioxidant, antimicrobial, analgesic, anti-platelet, anti-HIV. INTRODUCTION sulfisoxazole, oxacillin, cycloserine and acivicin Nitrogen containing heterocycles with an have been in commercial use for many years. oxygen atom are considered as an important Cycloserine is the best known antibiotic drug class of compounds in medicinal chemistry that possess antitubercular, antibacterial because of their diversified biological activities and in treatment of leprosy. Acivicin is applications. The exploitation of a simple an antitumour, antileishmania drug, while molecule with different functionalities for the isoxaflutole is used as herbicidal drug. synthesis of heterocycles is a worthwhile Isoxazoles have illustrious history; their contribution in the chemistry of heterocycles.
    [Show full text]
  • Matrix Scientific PO BOX 25067 COLUMBIA, SC 29224-5067 Telephone: 803-788-9494 Fax: 803-788-9419 SAFETY DATA SHEET Transportation Emergency: 3E Co
    Matrix Scientific PO BOX 25067 COLUMBIA, SC 29224-5067 Telephone: 803-788-9494 Fax: 803-788-9419 SAFETY DATA SHEET Transportation Emergency: 3E Co. (5025) 800-451-8346 1. Product Identification Name Oxazolidine-2,5-dione Catalog Number 094908 CAS Registry Number [2185-00-4] Company Matrix Scientific Physical Address 131 Pontiac Business Center Drive Elgin, SC 29045 USA Telephone/Fax (803)788-9494/(803)788-9419 2. Hazard Identification Hazardous Ingredients Oxazolidine-2,5-dione GHS label elements, including precautionary statements Pictogram Signal word WARNING Hazard statement(s) H317 May cause an allergic skin reaction H319 Causes serious eye irritation Precautionary statement(s) P280 Wear protective gloves/protective clothing/eye protection/face protection. P305+351+338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. 3. Composition, Information or Ingredients Name Oxazolidine-2,5-dione 4. First Aid Measures Eye Contact: Check for and remove any contact lenses. Immediately flush 1 Last Updated 2/11/2017 eyes with clean, running water for at least 15 minutes while keeping eyes open. Cool water may be used. Seek medical attention. Skin Contact: After contact with skin, wash with generous quantities of running water. Gently and thoroughly wash affected area with running water and non- abrasive soap. Cool water may be used. Cover the affected area with emollient. Seek medical attention. Wash any contaminated clothing prior to reusing. Inhalation: Remove the victim from the source of exposure to fresh, uncontaminated air. If victim's breathing is difficult, administer oxygen. Seek medical attention.
    [Show full text]
  • Block-Poly(2-Methyl-2-Oxazoline)
    ENGINEERING OF POLY(2-OXAZOLINE)S FOR A POTENTIAL USE IN BIOMEDICAL APPLICATIONS by Camille Legros A thesis presented to the University of Waterloo, Université de Liege and Université de Bordeaux in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in Chemical Engineering (Nanotechnology) Waterloo, Ontario, Canada, 2015 © Camille Legros 2015 'I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public.' ii iii Abstract Résumé: Ce travail décrit d'abord l’élaboration de nanogels hydrophiles stimulables, sensibles à un changement de pH et à un environnement où les propriétés d’oxydo-réduction peuvent varier. Ils ont été synthétisés en milieu dilué, d’une part, et en émulsion inverse, d’autre part; dans les deux cas à partir d’un copolymère statistique composé d’unités 2-éthyl-2-oxazoline et éthylène imine. Ces nanogels n’ont pas montré d’interactions spécifiques avec des protéines telles que la BSA et se sont avérés non-toxiques in vitro. Une plateforme à base d’un copolymère POx statistique porteur de fonctions aldéhydes a par ailleurs permis d’accéder à une librairie de POx, incluant des structures greffées et réticulées. Enfin, l’auto-assemblage en solution d’un copolymère à blocs de type poly(2-methyl-oxazoline)-b-poly(2-isopropyl-2-oxazoline) (PMeOx- b-PiPrOx), a été étudié en détail. Des micelles ont été observées à des temps courts au-dessus du point trouble du PiPrOx.
    [Show full text]
  • Novel Functional Poly(2-Oxazoline)S As Potential Carriers for Biomedical Applications
    Technische Universität München Department Chemie WACKER-Lehrstuhl für Makromolekulare Chemie Novel Functional Poly(2-oxazoline)s as Potential Carriers for Biomedical Applications Robert Luxenhofer Vollständiger Abdruck der von der Fakultät für Chemie der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. Kai-Olaf Hinrichsen Prüfer der Dissertation: 1. Priv.-Doz. Dr. Rainer Jordan 2. Univ.-Prof. Dr. Horst Kessler 3. Univ.-Prof. Dr. Andreas Türler Die Dissertation wurde am 29.05.2007 bei der Technischen Universität München ein- gereicht und durch das Department Chemie am 26.06.2007 angenommen. In Vivo Veritas! Die vorliegende Arbeit wurde am WACKER-Lehrstuhl für Makromolekulare Chemie (zuvor Lehrstuhl für Makromolekulare Stoffe) im Department Chemie der Technischen Universität München in der Zeit von März 2004 bis Mai 2007 unter der Leitung von Herrn PD Dr. Rainer Jordan angefertigt. Insbesondere möchte ich mich bei meinem Mentor und Betreuer PD Dr. Rainer ´Ray´ Jordan sehr herzlich bedanken, dass er mir die Möglichkeit gegeben hat, an diesem Projekt zu arbeiten. Ich glaube das war die interessanteste Doktorarbeit die ich hätte finden können, selbst wenn ich gesucht hätte. Ich war sehr froh über all die Freiheit die ich hatte, wobei man immer vorbeikommen konnte, wenn man ein Problem hatte. Außerdem bin ich dankbar für die Arbeits- und Konferenzaufenthalte in New York, Flic en Flac, Budapest, San Francisco etc., die ich genießen konnte und die große Geduld mit mir. Prof. Dr.-Ing. Oskar Nuyken und Prof. Dr. Bernhard Rieger danke ich für die Auf- nahme bzw. die Möglichkeit meines Verbleibs am Lehrstuhl.
    [Show full text]
  • A New Class of Anticancer Agents
    Chem Biol Drug Des 2014; 83: 126–131 Research Letter Mefloquine–Oxazolidine Derivatives: A New Class of Anticancer Agents Felipe A. R. Rodrigues1, Igor da S. Bomfim1, applications in other fields, such as against Gram-positive Bruno C. Cavalcanti1, Claudia Pessoa1, Raoni and Gram-negative bacteria (1), in particular against Myco- S. B. Goncalves2, James L. Wardell2,3, Solange bacterium tuberculosis (2,3) and Mycobacterium avium M. S. V. Wardell4 and Marcus V. N. de Souza2,* complex (MAC) (4,5) and also against schistosomiasis (6), neurodegenerative, and (neuro-) inflammatory diseases (7). 1Laboratorio de Oncologia Experimental, Universidade A clear indication of the promise of this drug in fields other Federal do Ceara, Fortaleza, CE 3157, Brazil than malaria is the number of recent patent applications 2FioCruz-Fundacßao~ Oswaldo Cruz, Instituto de Tecnologia (5,7,8). More recently, much attention has been paid to the em Farmacos-Far-Manguinhos, Rua Sizenando Nabuco, potential perspectives of MQ as an anticancer agent. As 100, Manguinhos, 21041-250, Rio de Janeiro, RJ 35513, estimated by the National Institutes of Health (NIH), the over- Brazil all costs of cancer in 2007 were $226.8 billion.a Cancer is a 3Department of Chemistry, University of Aberdeen, Old leading cause of deaths worldwide and accounted for 7.6 Aberdeem, Aberdeem, AB 24 3UE, UK b 4CHEMSOL, 1 Harcourt Road, Aberdeen, AB15 5NY, UK million deaths (13% of all deaths) in 2008. Louie and *Corresponding author: Marcus V. N. de Souza, coworkers (9) found MQ to be the most potent anticancer marcos_souza@far.fiocruz.br drug when compared to chloroquine and the fluoroquino- lone drugs cipro and levofloxacin.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 5,977,285 Ernst MOOS Et Al
    USOO5977285A United States Patent (19) 11 Patent Number: 5,977,285 Ernst MOOS et al. (45) Date of Patent: Nov. 2, 1999 54 SPRAYABLE COATING COMPOSITIONS 992721 5/1965 United Kingdom. WO 92/13907 8/1992 WIPO ............................ CO8G 18/10 COMPRISING OXAZOLIDINES, ISOCYANATES AND HYDROXYL OR AMINE WO 93/17060 9/1993 WIPO ............................ CO8G 63/02 FUNCTIONAL RESNS WO 94/27746 12/1994 WIPO .............................. BO5D 7/24 WO95/14528 6/1995 WIPO .............................. B01J 13/OO (75) Inventors: Jan Wilhelm Ernst Moos, Bloomfield WO 96/083O8 3/1996 WIPO .............................. B01J 13/OO Hills; Heide Anne Lochbiler, East OTHER PUBLICATIONS Pointe; Jason Donald Weaver, New Angus Chemical Company Technical Bulletin TB 91 Zol Baltimore; Latoska Nikita Price, dine(R) RD-20, 1–8 (1994). Southfield; Frances Lamb, Northville; International Search Report, dated Nov. 27, 1998 (PCT/ Donald Lynn Rutledge, Jr., Clawson, EP98/04942). all of Mich.; Ann Alfred Johanna International Search Report, dated Dec. 4, 1998 (PCT/EP98/ Lemaire, Leiderdorp, Netherlands; 04943). Antonius Hendrikus Gerardus Van International Search Report, dated Dec. 11, 1998 (PCT/ Engelen, Alphen A/D Rijn, Netherlands; EP98/04944). Catharine Marie den Breejen, Rohm and Haas Comppany Acryloid(R) Resins, Maintenance Dordrecht, Netherlands and Marine Coatings, Experimental Reactive Modifier QM-1007M, Reactive Diluent for Increasing Paint Solids Assignee: Akzo Nobel N.V., Netherlands and Improving Film Build of Acrylic-Urethane Coating, 1990, pp. 1–20. Appl. No.: 08/906,645 Donald C. Schall, High Solids Isocyanate-Oxazolidine Filed: Aug. 7, 1997 Coatings, Presented at the Water-Borne & High-Solids coatings Symposium, Feb. 13-15, 1985, New Orleans, Loui Int.
    [Show full text]
  • And Enantioselective Synthesis of P-Hydroxy-A-Amino Acids by Condensation of Aldehydes and Ketones with Glycine
    4252 J. Am. Chem. SOC.1985, 107, 4252-4259 mL and DMF and saturated with methylamine gas at 0 OC. The vessel mL volume) joined to the solvent distillation apparatus, waste, and was sealed and agitated for 1 day. The polymer was washed successively vacuum pump via Teflon tubing. in dioxane, ethanol, 2 N NaOH/i-PrOH (l:l), water (until eluate neu- In summary, we have shown for the first time the possibility to per- tral), ethanol, and ether. After drying in vacuo, the polymer (3.7 g/3.8 form highly efficient condensation reactions, by transferring polymer- mequiv of amino groups/l g of dry weight) was suspended in a mixture bound electrophiles (Le., active esters) via a mediator (shadchan) to of water (1.5 mL), ethanol (0.5 mL), triethylamine (7 mL), and 4- polymer-bound nucleophiles (i.e., amines). We have also shown the chloropyridine hydrochloride (4.7 g) in a glass pressure vessel, sealed and possibility of on-line monitoring which is relevant for automation. heated for 4 days at 140 OC. The polymer was washed as before, and The mediator methodology developed here is believed not to be limited unreacted amino groups were blocked by acetylation (acetic anhydride to acylation and related processes but to be expandable to other chemical in CH2C12,then base wash). The washed DMAP polymer was dried at processes that involve the creation of activated intermediates. These 150 OC in vacuo until constant weight. Incorporation of pyridine groups possibilities are currently under investigation. was determined by potentiometric chloride titration of the hydrochloride salt bound to the polymer: 2.53 mequiv/g compared to 3.15 mequiv/g Acknowledgment.
    [Show full text]
  • European Patent Office Office Europeenpeen Des Brevets EP 0 674 618 B1
    Europaisches Patentamt (19) European Patent Office Office europeenpeen des brevets EP 0 674 618 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) intci.6: C07C 317/32, C07C 233/22, of the grant of the patent: C07C 315/04, C07D 301/19, 09.09.1998 Bulletin 1998/37 C07D 263/14, A61K31/16 (21) Application number: 94903599.2 (86) International application number: PCT/US93/12071 (22) Date of filing: 15.12.1993 (87) International publication number: WO 94/14764 (07.07.1994 Gazette 1994/15) (54) ASYMMETRIC PROCESS FOR PREPARING FLORFENICOL, THIAMPHENICOL, CHLORAMPHENICOL AND OXAZOLINE INTERMEDIATES ASYMMETRISCHES HERSTELLUNGSVERFAHREN FUR FLORFENICOL, THIAMPHENICOL, CHLORAMPHENICOL UND OXAZOLIN-ZWISCHENPRODUKTE PROCEDE ASYMETRIQUE DE PREPARATION DE FLORFENICOL, THIAMPHENICOL, CHLORAMPHENICOL ET D'INTERMEDI AIRES OXAZOLINE (84) Designated Contracting States: (74) Representative: AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT von Kreisler, Alek, Dipl.-Chem. et al SE Patentanwalte, von Kreisler-Selting-Werner, (30) Priority: 18.12.1992 US 993932 Bahnhofsvorplatz 1 (Deichmannhaus) 50667 Koln (DE) (43) Date of publication of application: 04.10.1995 Bulletin 1995/40 (56) References cited: EP-A- 0 423 705 EP-A- 0 472 790 (73) Proprietor: SCHERING CORPORATION WO-A-92/07824 US-A- 4 235 892 Kenilworth New Jersey 07033 (US) US-A- 4 876 352 US-A- 4 900 847 (72) Inventors: • CHEMICAL ABSTRACTS, vol. 107, no. 1, 06 July • WU, Guang-Zhong 1987, Columbus, Ohio, US; abstract no. 6859M, Somerville, NJ 08876 (US) JOMMI, GIANCARLO ET AL '2-Oxazolidinones • TORMOS, Wanda, I. as regioselective protection of beta-amino Elizabeth, NJ 07202 (US) alcohols in the synthesis of 2-amino-1-aryl-3-fluoro-1-propanols' page 632; column 1; & GAZZ.
    [Show full text]